S

Steven I. Sherman

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-3079-5153

411 papers and 56.9k citations.

PubIndex Score96Top 4% · seniorHow it's scored

411Publications

56.9kTotal Citations

First publication: 1955First senior author: 1955

Top publicationsby citations

A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1

Bryan R. Haugen, E. Chester Ridgway, Terry F. Davies et al.|The Journal of Clinical Endocrinology & Metabolism|1999

Cited by 564

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer

Razelle Kurzrock, Ravi Salgia, Steven I. Sherman et al.|Journal of Clinical Oncology|2011

Cited by 551

Thyroid Carcinoma

R. Michael Tuttle, Lori J. Wirth, Douglas W. Ball et al.|Journal of the National Comprehensive Cancer Network|2010

Cited by 205

Thyroid Carcinoma, Version 2.2014

R. Michael Tuttle, Miranda Hughes, Robert I. Haddad et al.|Journal of the National Comprehensive Cancer Network|2014

Cited by 200

A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone Withdrawal

Pamela Schroeder, Paul W. Ladenson, Bryan R. Haugen et al.|The Journal of Clinical Endocrinology & Metabolism|2006

Cited by 198

Indexing the rest of 411 publications…